![TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection - eBioMedicine TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection - eBioMedicine](https://www.thelancet.com/cms/attachment/eec7e856-0f2a-42f2-b61a-b861089a65d5/gr3_lrg.jpg)
TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection - eBioMedicine
![Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options - ScienceDirect Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S000649712100985X-grabsf1.jpg)
Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options - ScienceDirect
![Homogenous TP53mut-associated tumor biology across mutation and cancer types revealed by transcriptome analysis | Cell Death Discovery Homogenous TP53mut-associated tumor biology across mutation and cancer types revealed by transcriptome analysis | Cell Death Discovery](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41420-023-01413-1/MediaObjects/41420_2023_1413_Fig1_HTML.png)
Homogenous TP53mut-associated tumor biology across mutation and cancer types revealed by transcriptome analysis | Cell Death Discovery
![Probability Distributions of p53 Mutations and Their Corresponding Shannon Entropies in Different Cancer Cell Types | SpringerLink Probability Distributions of p53 Mutations and Their Corresponding Shannon Entropies in Different Cancer Cell Types | SpringerLink](https://media.springernature.com/lw685/springer-static/image/chp%3A10.1007%2F978-3-031-12515-7_3/MediaObjects/527717_1_En_3_Fig3_HTML.png)
Probability Distributions of p53 Mutations and Their Corresponding Shannon Entropies in Different Cancer Cell Types | SpringerLink
![A TP53-Associated Immune Prognostic Signature for the Prediction of Overall Survival and Therapeutic Responses in Muscle-Invasive Bladder Cancer - Frontiers A TP53-Associated Immune Prognostic Signature for the Prediction of Overall Survival and Therapeutic Responses in Muscle-Invasive Bladder Cancer - Frontiers](https://www.frontiersin.org/files/MyHome%20Article%20Library/590618/590618_Thumb_400.jpg)
A TP53-Associated Immune Prognostic Signature for the Prediction of Overall Survival and Therapeutic Responses in Muscle-Invasive Bladder Cancer - Frontiers
Targeting Cavity-Creating p53 Cancer Mutations with Small-Molecule Stabilizers: the Y220X Paradigm | ACS Chemical Biology
![TP53 exon-6 truncating mutations produce separation of function isoforms with pro-tumorigenic functions | eLife TP53 exon-6 truncating mutations produce separation of function isoforms with pro-tumorigenic functions | eLife](https://iiif.elifesciences.org/lax/17929%2Felife-17929-fig1-figsupp2-v4.tif/full/1500,/0/default.jpg)
TP53 exon-6 truncating mutations produce separation of function isoforms with pro-tumorigenic functions | eLife
![High prevalence of TP53 loss and whole-genome doubling in early-onset colorectal cancer | Experimental & Molecular Medicine High prevalence of TP53 loss and whole-genome doubling in early-onset colorectal cancer | Experimental & Molecular Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs12276-021-00583-1/MediaObjects/12276_2021_583_Fig1_HTML.png)
High prevalence of TP53 loss and whole-genome doubling in early-onset colorectal cancer | Experimental & Molecular Medicine
![TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection - eBioMedicine TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection - eBioMedicine](https://www.thelancet.com/cms/attachment/582b61e3-c8c7-499e-9785-188e8a092ad3/gr1_lrg.jpg)
TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection - eBioMedicine
![Frontiers | Promising New Tools for Targeting p53 Mutant Cancers: Humoral and Cell-Based Immunotherapies Frontiers | Promising New Tools for Targeting p53 Mutant Cancers: Humoral and Cell-Based Immunotherapies](https://www.frontiersin.org/files/Articles/707734/fimmu-12-707734-HTML/image_m/fimmu-12-707734-g001.jpg)
Frontiers | Promising New Tools for Targeting p53 Mutant Cancers: Humoral and Cell-Based Immunotherapies
![Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis | Nature Communications Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-35727-y/MediaObjects/41467_2022_35727_Fig1_HTML.png)
Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis | Nature Communications
![Gain of function in somatic TP53 mutations is associated with immune‐rich breast tumors and changes in tumor‐associated macrophages - Behring - 2019 - Molecular Genetics & Genomic Medicine - Wiley Online Library Gain of function in somatic TP53 mutations is associated with immune‐rich breast tumors and changes in tumor‐associated macrophages - Behring - 2019 - Molecular Genetics & Genomic Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/90dcaaaa-408c-4a61-9b65-1dc422dcfb2b/mgg31001-toc-0001-m.jpg?trick=1699980891962)
Gain of function in somatic TP53 mutations is associated with immune‐rich breast tumors and changes in tumor‐associated macrophages - Behring - 2019 - Molecular Genetics & Genomic Medicine - Wiley Online Library
![Omics analyses of a somatic Trp53R245W/+ breast cancer model identify cooperating driver events activating PI3K/AKT/mTOR signaling | PNAS Omics analyses of a somatic Trp53R245W/+ breast cancer model identify cooperating driver events activating PI3K/AKT/mTOR signaling | PNAS](https://www.pnas.org/cms/10.1073/pnas.2210618119/asset/78c1710e-4888-481d-8309-0b3a105712dc/assets/images/large/pnas.2210618119fig01.jpg)
Omics analyses of a somatic Trp53R245W/+ breast cancer model identify cooperating driver events activating PI3K/AKT/mTOR signaling | PNAS
![Mutant p53 achieved Gain-of-Function by promoting tumor growth and immune escape through PHLPP2/AKT/PD-L1 pathway Mutant p53 achieved Gain-of-Function by promoting tumor growth and immune escape through PHLPP2/AKT/PD-L1 pathway](https://www.ijbs.com/v18/p2419/toc.jpg)
Mutant p53 achieved Gain-of-Function by promoting tumor growth and immune escape through PHLPP2/AKT/PD-L1 pathway
![Gastrointestinal Disorders | Free Full-Text | Prognostic Impact of TP53 Mutations and Tumor Mutational Load in Colorectal Cancer Gastrointestinal Disorders | Free Full-Text | Prognostic Impact of TP53 Mutations and Tumor Mutational Load in Colorectal Cancer](https://www.mdpi.com/gastrointestdisord/gastrointestdisord-04-00016/article_deploy/html/images/gastrointestdisord-04-00016-g002.png)
Gastrointestinal Disorders | Free Full-Text | Prognostic Impact of TP53 Mutations and Tumor Mutational Load in Colorectal Cancer
![LRP1B or TP53 mutations are associated with higher tumor mutational burden and worse survival in hepatocellular carcinoma LRP1B or TP53 mutations are associated with higher tumor mutational burden and worse survival in hepatocellular carcinoma](https://www.jcancer.org/ms/getimage.php?name=jcav12p0217g005.jpg)
LRP1B or TP53 mutations are associated with higher tumor mutational burden and worse survival in hepatocellular carcinoma
![Diverse rescue potencies of p53 mutations to ATO are predetermined by intrinsic mutational properties | Science Translational Medicine Diverse rescue potencies of p53 mutations to ATO are predetermined by intrinsic mutational properties | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.abn9155/asset/f93e4759-81c1-41bb-ac83-4b3dd30f8f14/assets/images/large/scitranslmed.abn9155-f1.jpg)